ELMO1 helps cells move and clear away unwanted material, supporting normal healing and immune defense. This gene plays an important role in guiding how certain cells change shape and travel through tissues. The protein made by the ELMO1 gene works with partner proteins to control these movement signals. When the ELMO1 gene works less well, cleanup and cell migration can be reduced, and some variants are linked to a higher risk of diabetic kidney disease.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make certain molecules or to guide how the body carries out specific tasks. Some genes provide the recipe for proteins, which do much of the day-to-day work inside cells. Others are involved mainly in regulating timing, location, and intensity of different body processes. Taken as a whole, genes help direct growth and normal body function, and they can also affect how you react to things like food, stress, or medicines. More detailed information on this topic is available in the LearnHub.
Overview
ELMO1Gene function
What if the gene works
In your body, the ELMO1 gene helps certain cells move and change shape, supporting wound healing and immune cleanup. It also helps cells engulf and clear debris and dying cells, keeping tissues orderly.
Risk
What if the gene does not work
Changes that reduce ELMO1 activity can affect how kidney cells respond to injury and may increase the chance of diabetic kidney disease and kidney scarring. Effects range from subtle risk shifts to stronger mutations, influencing onset and severity.
Treatment
What does that mean for your treatment
ELMO1 variants do not currently guide medication selection, so treatment typically follows standard guidelines for your condition. No proven gene targeted or compensating gene therapy exists for ELMO1. Results may mainly inform research or closer monitoring rather than changing drugs.
Gene function
What if the gene works
In everyday life, your cells need to move into the right place and clear away what is no longer needed. These tasks matter for routine immune work, tissue upkeep, and healing after minor damage. Across many tissues, the ELMO1 gene contributes to steady, routine cell activity by helping cells coordinate movement and “cleanup” behaviors.
One of the main jobs of the ELMO1 gene is to help cells move in a directed way. It supports the internal rearrangements cells use to crawl toward a target, such as immune cells moving through tissue.
A key part of ELMO1 gene function is helping cells engulf and remove unwanted material, like cell debris. This supports normal “housekeeping” that keeps tissues orderly and helps the immune system do routine cleanup.
The ELMO1 gene helps cells change shape in a controlled, coordinated way. These shape changes support how cells spread, form stable contact with their surroundings, and carry out movement and cleanup tasks.
What is a variant?
A genetic variant is a minor difference in a gene’s DNA code. These differences are very common and are one reason people naturally vary, including in traits like appearance, metabolism, and how the body reacts to environmental factors. Many variants do not cause any noticeable change and are simply part of normal genetic diversity. In certain situations, though, a variant can affect how a gene works more significantly and may play a role in, or directly lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the ELMO1 gene can shift how strongly kidney and immune cells move and respond to injury, which may influence long-term kidney health. Many reported ELMO1 gene variants and diabetic kidney disease links involve common, mild DNA changes that slightly alter gene activity, nudging risk upward rather than causing a diagnosis. Rarer, more disruptive mutations could reduce or stop ELMO1 function, and may be tied to earlier onset, more noticeable kidney findings, or different symptom patterns.
How variants are linked to conditions
Some genetic changes can influence a person’s chances of developing kidney complications, especially in the setting of diabetes. Variants in the ELMO1 gene have been linked in multiple studies to diabetic nephropathy (diabetes related kidney disease), including a higher likelihood of reduced kidney function and, in some people, progression to chronic kidney disease. These ELMO1 gene and diabetic nephropathy risk associations describe population trends and do not guarantee that any one person will develop kidney disease.
A variant is not necessarily a diagnosis
Differences in DNA are a typical feature of human biology, and they occur frequently across the population. In most cases, these variants do not directly affect health and instead represent normal human diversity. For many genes, having a variant that has been linked to a condition points to a possible connection rather than confirming that you have the condition, particularly when risk depends on many genes along with environmental influences. In other situations, a single well-studied variant in a particular gene can be enough to establish a diagnosis.
Are there things that can increase or change my risk?
Changes in the ELMO1 gene can influence a person’s tendency toward kidney problems, but they do not make kidney disease inevitable. In people with diabetes, high blood sugar, high blood pressure, smoking, and long-standing diabetes can raise the chance of kidney damage. There is not enough evidence to say any lifestyle step specifically offsets ELMO1-related risk, but good diabetes and blood pressure control helps protect kidneys overall.
Inheritance of ELMO1 variants
Variants in the ELMO1 gene are usually inherited in families in an autosomal way, meaning they can be passed down from either parent and are not tied to biological sex. You inherit two copies of the gene, one from each parent, so relatives may share the same change. This pattern of ELMO1 gene inheritance can also include rare new (de novo) changes that first appear in a child.
What does my ELMO1 result mean for my family?
Seek medical advice if an ELMO1 result raises worries about kidney problems, especially with diabetes, swelling in the legs, or foamy urine. A healthcare professional can help explain what the result may mean for close relatives and whether family members should pay extra attention to kidney and blood pressure checks. ELMO1 information can also guide how closely your care team monitors kidneys and manages risks.
Genetic information
Genetic testing
How you find out about variants
Genetic testing can show whether you carry changes in the ELMO1 gene that may be linked to certain health risks in some families. ELMO1 genetic testing is usually done on a blood or saliva sample, where a lab reads the DNA code and compares it with a reference to spot variants. Results are reported as benign, uncertain, or pathogenic findings.
When should I consider getting a genetic test?
Consider genetic testing that includes the ELMO1 gene if you or relatives have kidney disease at a young age, kidney problems that seem to run in the family, or unusually severe kidney damage with diabetes. Testing can sometimes help clarify whether an inherited gene change may be contributing and guide screening for family members. Discuss results with a genetics professional.
A genetic result is only one part of your health story
Genetic results can be very informative, but the amount they explain varies with the condition and the specific kind of variant. Over time, how your body functions is shaped by many factors, including lifestyle, environment, age, and your medical history. For some health conditions, particularly those influenced by many genes, genetic information provides helpful background rather than a definite prediction and makes the most sense when considered along with other parts of care. In other situations, a genetic finding can give a straightforward conclusion. For topics like how someone responds to medications, genetic results can help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, and this is a common reason the same treatment works well for one person but not another. Variants can change how quickly your body breaks down a drug, how strongly a drug acts on its target, or how likely certain side effects are. The ELMO1 gene is mainly studied for its role in how cells move and respond to signals, and it does not have a widely established, routine pharmacogenetic use for guiding medication choices. Medication response still depends on many factors beyond genes, including age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in your genes can affect the way you respond to medicines. It examines links between specific genes and medications to clarify why the same treatment can have different effects in different people. For many drugs, genetics can influence how powerfully a medication works and how your body breaks it down. This understanding can support more informed, more personalized treatment choices. More information on this topic is available in the LearnHub.
Drugs influenced by the ELMO1 gene
When should I seek medical advice?
If you have diabetes and develop leg swelling, foamy urine, or rising blood pressure, seek medical advice, since these can be signs of kidney strain. Tell your clinician if you’ve been told you have a change in the ELMO1 gene so they can weigh it with your lab results. Get urgent care for shortness of breath, chest pain, or confusion.
History
The ELMO1 gene was first characterized in the early 2000s through research exploring how cells move and change shape during normal body processes. In recent decades, awareness of this gene’s role has grown as genetic studies began linking ELMO1 to certain long term health outcomes. By the mid to late 2000s, several research groups reported associations between DNA changes near ELMO1 and susceptibility to diabetic kidney disease in some populations. Follow up studies over the next years tested these findings in different groups of people, helping clarify that results can vary by ancestry and by the specific genetic change studied. As larger genetic databases and research tools expanded, ELMO1 continued to appear in studies focused on kidney complications of diabetes and related vascular changes.